TD Cowen on Boston Scientific (BSX): 'Data Reinforce Strong Growth Outlooks for FARAPULSE and WATCHMAN'

January 17, 2025 12:36 PM EST Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $110.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login